Skip to main content
. 2022 Nov 18;101(46):e31918. doi: 10.1097/MD.0000000000031918

Figure 3.

Figure 3.

The subgroup survival analysis of patients without specific tyrosine kinase inhibitors therapy. (A) Progression-free survival. (B) Overall survival. DLT = definitive local therapy.